SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-132323
Filing Date
2011-05-09
Accepted
2011-05-09 16:06:47
Documents
6
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10-Q d10q.htm 10-Q 504886
2 2011 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS dex101.htm EX-10.1 9331
3 MASTER SERVICES AGREEMENT dex102.htm EX-10.2 140656
4 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex311.htm EX-31.1 9867
5 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex312.htm EX-31.2 9859
6 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 5707
  Complete submission text file 0001193125-11-132323.txt   681277
Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304
Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777
JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 050563787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 11823554
SIC: 2834 Pharmaceutical Preparations